<DOC>
	<DOCNO>NCT01575574</DOCNO>
	<brief_summary>This study evaluate primovist new contrast agent useful diagnostic hepatocellular carcinoma</brief_summary>
	<brief_title>Magnetic Resonance With Gadoxetic Acid Diagnosis Hepatocellular Carcinoma Patients With Liver Cirrhosis . Evaluation Its Impact Non-invasive Diagnosis</brief_title>
	<detailed_description>The investigator plan define imaging pattern hepatocellular carcinoma cirrhotic patient study gadoxetic acid magnetic resonance image include dynamic phase hepatobiliary phase 10 20 minute contrast injection evaluate usefulness liver magnetic resonance image gadoxetic acid differentiation benign malignant nodule cirrhotic liver . To determine diagnosis clinical significance infracentimetric additional nodule detect hepatobiliary phase</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>18 year old patient diagnosis liver cirrhosis Child Pugh AB Patients without previous hepatocellular carcinoma ultrasound detect suspicious hepatic lesion ; solitary solid welldefined nodule 10 20mm patient diagnosis hepatocellular carcinoma clinical need prior treatment indication patient agree participate signing informed consent form Patients poor liver function would undergo transplantation even without hepatocellular carcinoma diagnosis ( ChildPugh C ) patient previous diagnosis hepatocellular carcinoma patient significant comorbidities could prevent optimum therapeutic decision case positive diagnosis hepatocellular carcinoma patient severe clot alteration contraindicate fineneedle biopsy Patients chronic kidney disease glomerular filtration rate &lt; 30 ml/min patient contraindication perform magnetic resonance imaging ( pacemaker , claustrophobia ... ) Known hypersensitivity study drug excipients pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>